Cargando…

Pharmacology of Chloroquine and Hydroxychloroquine

The 4-aminoquinolines are weak bases that are completely absorbed from the gastrointestinal tract, sequestered in peripheral tissues, metabolized in the liver to pharmacologically active by-products, and excreted via the kidneys and the feces. The parent drugs and metabolites are excreted with a hal...

Descripción completa

Detalles Bibliográficos
Autor principal: Browning, David J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7122276/
http://dx.doi.org/10.1007/978-1-4939-0597-3_2
_version_ 1783515382525460480
author Browning, David J.
author_facet Browning, David J.
author_sort Browning, David J.
collection PubMed
description The 4-aminoquinolines are weak bases that are completely absorbed from the gastrointestinal tract, sequestered in peripheral tissues, metabolized in the liver to pharmacologically active by-products, and excreted via the kidneys and the feces. The parent drugs and metabolites are excreted with a half-life of elimination of approximately 40 days. However, slow release from sequestered stores of the drugs means that after discontinuation, they continue to be released into the plasma for years. Correct dosing is based on the ideal body weight of the patient, which depends on height. The 4AQs diminish autoimmunity without compromising immunity to infections.
format Online
Article
Text
id pubmed-7122276
institution National Center for Biotechnology Information
language English
publishDate 2014
record_format MEDLINE/PubMed
spelling pubmed-71222762020-04-06 Pharmacology of Chloroquine and Hydroxychloroquine Browning, David J. Hydroxychloroquine and Chloroquine Retinopathy Article The 4-aminoquinolines are weak bases that are completely absorbed from the gastrointestinal tract, sequestered in peripheral tissues, metabolized in the liver to pharmacologically active by-products, and excreted via the kidneys and the feces. The parent drugs and metabolites are excreted with a half-life of elimination of approximately 40 days. However, slow release from sequestered stores of the drugs means that after discontinuation, they continue to be released into the plasma for years. Correct dosing is based on the ideal body weight of the patient, which depends on height. The 4AQs diminish autoimmunity without compromising immunity to infections. 2014-04-04 /pmc/articles/PMC7122276/ http://dx.doi.org/10.1007/978-1-4939-0597-3_2 Text en © Springer Science+Business Media New York 2014 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Article
Browning, David J.
Pharmacology of Chloroquine and Hydroxychloroquine
title Pharmacology of Chloroquine and Hydroxychloroquine
title_full Pharmacology of Chloroquine and Hydroxychloroquine
title_fullStr Pharmacology of Chloroquine and Hydroxychloroquine
title_full_unstemmed Pharmacology of Chloroquine and Hydroxychloroquine
title_short Pharmacology of Chloroquine and Hydroxychloroquine
title_sort pharmacology of chloroquine and hydroxychloroquine
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7122276/
http://dx.doi.org/10.1007/978-1-4939-0597-3_2
work_keys_str_mv AT browningdavidj pharmacologyofchloroquineandhydroxychloroquine